What are the Medicare stage B heart failure criteria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medicare Stage B Heart Failure Criteria

Stage B heart failure (pre-heart failure) is defined as structural heart disease without current or previous symptoms or signs of heart failure. 1

Definition and Diagnostic Criteria for Stage B Heart Failure

Stage B heart failure includes patients who meet the following criteria:

  • No current or previous symptoms or signs of heart failure 1
  • Evidence of at least one of the following: 1
    • Structural heart disease
      • Reduced left or right ventricular systolic function
      • Reduced ejection fraction or reduced strain
      • Ventricular hypertrophy
      • Chamber enlargement
      • Wall motion abnormalities
      • Valvular heart disease
    • Evidence of increased filling pressures
      • By invasive hemodynamic measurements
      • By noninvasive imaging suggesting elevated filling pressures
    • Risk factors with increased natriuretic peptide levels or persistently elevated cardiac troponin in the absence of competing diagnoses 1

Common Examples of Stage B Heart Failure

Patients with Stage B heart failure commonly include those with: 1

  • Previous myocardial infarction 1
  • Known structural heart disease 1
  • Asymptomatic valvular disease 1
  • LV hypertrophy or LV dysfunction without symptoms 1

Clinical Significance and Management

Stage B heart failure represents a critical opportunity for prevention of symptomatic heart failure. Management recommendations include:

  • ACE inhibitors or ARBs in appropriate patients with a history of MI and reduced EF to prevent progression to symptomatic heart failure 1
  • Evidence-based beta blockers in patients with MI and reduced EF 1
  • Statins in patients with a history of MI to prevent heart failure 1
  • Blood pressure control according to published guidelines 1
  • Implantable cardioverter-defibrillators may be reasonable in selected patients (e.g., those with asymptomatic ischemic cardiomyopathy who are at least 40 days post-MI, have LVEF ≤30%, and are on guideline-directed medical therapy) 1

Evolution of Stage B Criteria

It's important to note that the definition of Stage B heart failure has evolved over time:

  • The 2005 ACC/AHA guidelines defined Stage B simply as "structural heart disease but without signs or symptoms of HF" 1
  • The 2022 ACC/AHA/HFSA guidelines expanded the definition to include objective evidence of increased filling pressures and biomarker criteria 1

Clinical Pearls and Pitfalls

  • Avoid nondihydropyridine calcium channel blockers with negative inotropic effects in patients with low LVEF, as they may be harmful 1
  • Stage B represents a critical intervention point where appropriate medical therapy can prevent progression to symptomatic heart failure (Stage C) 1
  • Regular monitoring of patients with Stage B heart failure is essential, as they remain at high risk for developing symptomatic heart failure 1
  • The trajectory of LVEF over time is important to evaluate, as patients with mildly reduced EF may be in a dynamic trajectory toward improvement or deterioration 1

Relationship to Other Classification Systems

Stage B heart failure typically includes patients who would be classified as NYHA Class I (no limitations on physical activity) if they have structural heart disease 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.